PETER J BARRIS Insider Trading $ADAP Adaptimmune Therapeutics PLC
Get free email notifications about insider trading for PETER J BARRIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER J BARRIS. PETER J BARRIS is in APPLIED IMAGING CORP ($AICX) and 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in OCCAM NETWORKS INC/DE ($OCCM) and in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in XTERA COMMUNICATIONS, INC. ($XCOM) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and 10% Owner in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and Director in VONAGE HOLDINGS CORP ($VG) and Director in Inteliquent, Inc. ($IQNT) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in INTERCELL USA, INC. ($IOMI) and Director in INNERWORKINGS INC ($INWK) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in Groupon, Inc. ($GRPN) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and Director in Sprout Social, Inc. ($SPT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Senseonics Holdings, Inc. ($SENS) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).
PETER J BARRIS in Adaptimmune Therapeutics PLC
Trading Symbol: ADAPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PETER J BARRIS: 10% Owner
Holdings: 82,978,668 shares
Current Value: $375,893,366
Latest Transaction: Sep 10 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PETER J BARRIS in Adaptimmune Therapeutics PLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, FOLD, APPN, AICX, ARDM, ABIO, ARDX, AVEO, CRCM, CASC, CBIO, CERC, DZSI, ESTC, EPZM, FOXH, GNCA, GLYC, GRPN, HPTX, INHX, INWK, IQNT, IOMI, ILIU, LIQDA, MRSN, MIRM, MULE, MYOG, OCCM, PRTK, PHRM, RARX, RGLS, RYTM, SENS, ROKA, SPT, SUPN, SURF, SYBX, TSRO, TCON, TRVI, VTAE, VG, XCOM, ZHNE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.92 | 6,000,000 | 11,500,200 | 79,978,672 | 74 M to 80 M (+8.11 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.90 | 571,164 | 1,087,553 | 73,978,672 | 73.4 M to 74 M (+0.78 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
Mar 28 2017 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 0.70 | 12,870,000 | 9,009,000 | 72,139,000 | 59.3 M to 72.1 M (+21.71 %) |
Page: 1